The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns

Surgical Endoscopy

Volumn 29, Issue 7, 2015, Pages 1888-1896

  Manner, Hendrik ^a   Pech, Oliver ^b   Heldmann, Yvonne ^a   May, Andrea ^c   Pauthner, Michael ^c   Lorenz, Dietmar ^c   Fisseler Eckhoff, Annette ^d   Stolte, Manfred ^e   Vieth, Michael ^f   Ell, Christian ^c  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Oncology and Hematology   (Germany)

^c SANA KLINIKUM OFFENBACH   (Germany)

^d HSK Hospital   (Germany)

^e Praxis Kulmbach   (Germany)

^f INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Early stage adenocarcinoma of the esophagus; Lymph node metastasis; sm1

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; EARLY CANCER; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LOW RISK PATIENT; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RISK ASSESSMENT; SUBMUCOSA; SURGICAL MORTALITY; TUMOR INVASION; ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; LYMPH NODE; MIDDLE AGED; MUCOSA; PATHOLOGY; PROCEDURES; RISK FACTOR; SECONDARY; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM STAGING; RISK FACTORS;

EID: 84935857371     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-014-3881-3     Document Type: Article

References (49)

1. Ell C, May A, Gossner L et al (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 118(4):670–677
2. Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A et al (2007) Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 65(1):3–10
3. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57(9):1200–1206
4. Pech O, May A, Manner H et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146(3):652–660
5. Nijhawan PK, Wang KK (2000) Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagus. Gastrointest Endosc 52(3):328–332
6. May A, Gossner L, Pech O, Müller H, Vieth M, Stolte M et al (2002) Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett’s esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endosc 34(8):604–610
7. Seewald S, Akaraviputh T, Seitz U, Brand B, Groth S, Mendoza G et al (2003) Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 57(7):854–859
8. Giovannini M, Bories E, Pesenti C, Moutardier V, Monges G, Danisi C et al (2004) Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36(9):782–787
9. Peters FP, Kara MA, Rosmolen WD, Aalders MCG, ten Kate FJW, Bultje BC et al (2005) Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest Endosc 61(4):506–514
10. Behrens A, May A, Gossner L, Günter E, Pech O, Vieth M et al (2005) Curative treatment for high-grade intraepithelial neoplasia in Barrett’s esophagus. Endosc 37(10):999–1005
11. Conio M, Cameron A, Chak A, Blanchi S, Filiberti R (2005) Endoscopic treatment of high-grade dysplasia and early cancer in Barrett’s oesophagus. Lancet Oncol 6:311–321
12. Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H et al (2007) Long-term follow-up of complete Barrett’s eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endosc 39(12):1086–1091
13. Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR (1997) Early adenocarcinoma in Barrett’s oesophagus. Br J Surg 84(10):1470–1473
14. Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349(23):2241–2252
15. Birkmeyer JD, Siewers AE, Finlayson EVA, Stukel TA, Lucas FL, Batista I et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128–1137
16. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349(22):2117–2127
17. Thomas P, Doddoli C, Neville P, Pons J, Lienne P, Giudicelli R et al (1996) Esophageal cancer resection in the elderly. Eur J Cardiothorac Surg 10(11):941–946
18. Braghetto I, Csendes A, Cardemil G, Burdiles P, Korn O, Valladares H (2006) Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival. Surg Endosc 20(11):1681–1686
19. Hölscher AH, Vallböhmer D, Bollschweiler E (2008) Early Barrett’s carcinoma of the esophagus. Ann Thorac Cardiovasc Surg 14(6):347–354
20. Rice TW (2006) Pro: esophagectomy is the treatment of choice for high-grade dysplasia in Barrett’s esophagus. Am J Gastroenterol 101(10):2177–2179
21. Buskens CJ, Westerterp M, Lagarde SM, Bergman JJGHM, ten Kate FJW, van Lanschot JJB (2004) Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 60(5):703–710
22. Westerterp M, Koppert LB, Buskens CJ, Tilanus HW, ten Kate FJW, Bergman JJHGM et al (2005) Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 446(5):497–504
23. Nigro JJ, Hagen JA, DeMeester TR, DeMeester SR, Peters JH, Oberg S et al (1999) Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 117(1):16–23; discussion 23–5
24. Stein HJ, Feith M, Bruecher BLDM, Naehrig J, Sarbia M, Siewert JR (2005) Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 242(4):566–573; discussion 573–575
25. Stein HJ, Feith M, Mueller J, Werner M, Siewert JR (2000) Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 232(6):733–742
26. Bollschweiler E, Baldus SE, Schröder W, Prenzel K, Gutschow C, Schneider PM et al (2006) High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endosc 38(2):149–156
27. Ancona E, Rampado S, Cassaro M, Battaglia G, Ruol A, Castoro C et al (2008) Prediction of Lymph Node Status in Superficial Esophageal Carcinoma. Ann Surg Oncol 15(11):3278–3288
28. Badreddine R, Prasad G, Lewis J et al (2010) Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. Clin Gastroenterol H 8:248–253
29. Sepesi B, Watson TJ, Zhou D, Polomsky M, Litle VR, Jones CE et al (2010) Are Endoscopic Therapies Appropriate for Superficial Submucosal Esophageal Adenocarcinoma? An Analysis of Esophagectomy Specimens. J Am Coll Surg 210(4):418–427
30. Hoelscher A, Bollschweiler E, Schroeder W et al (2011) Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg 254:802–808
31. Griffin SM, Burt AD, Jennings NA (2011) Lymph node metastasis in early esophageal adenocarcinoma. Ann Surg 254:731–737
32. Manner H, May A, Pech O, Gossner L, Rabenstein T, Günter E et al (2008) Early Barrett’s Carcinoma With “Low-Risk” Submucosal Invasion: Long-Term Results of Endoscopic Resection With a Curative Intent. Am J Gastroenterol 103(10):2589–2597
33. Manner H, Pech O, Heldmann Y et al (2013) Efficacy, safety, and Long-Term Results of Endoscopic Treatment for Early-Stage Adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 11(6):630–635
34. Alvarez Herrero L, Pouw RE, van Vilsteren FG, ten Kate FJW, Visser M, van Berge Henegouwen MI et al (2010) Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy 42(12):1030–1036
35. Association Japanese Gastric Cancer (1998) Japanese Classification of Gastric Carcinoma - 2nd English Edition -. Gastric Cancer 1(1):10–24
36. Koop H, Schepp W, Müller-Lissner S, Madisch A, Micklefield G, Messmann H et al (2005) Consensus Conference of the DGVS on Gastroesophageal Reflux. Z Gastroenterol 43(2):163–164
37. Hamilton S, Aalton L (eds) (2000) Pathology and Genetics of Tumours of the Digestive System: World Health Organization classification of tumours. International Agency for Research on Cancer (IARC) Press, Lyon
38. Sobin LH, Gospodarowicz MK, Wittekind CH (eds) (2009) TNM Classification of Malignant Tumours, 7th edn. Wiley-Blackwell, Oxford, pp 66–72
39. World Medical Association declaration of Helsinki (1997) Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277(11):925–926
40. Behrens A, Pech O, Graupe F, May A, Lorenz D, Ell C (2011) Barrett’s adenocarcinoma of the esophagus—better outcomes through new methods of diagnosis and treatment. Dtsch Arztebl Int 108(18):313–319
41. Birkmeyer JD, Sievers AE, Finlayson EV et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128–1137
42. van Sandick JW, van Lanschot JJ, ten Kate FJ, Offerhaus GJ, Fockens P, Tytgat GN et al (2000) Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 88(11):2429–2437
43. Rice TW, Boyce GA, Sivak MV, Adelstein DJ, Kirby TJ (1992) Esophageal carcinoma: esophageal ultrasound assessment of preoperative chemotherapy. Ann Thorac Surg 53(6):972–977
44. Pech O, May A, Günter E et al (2006) The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett’s esophagus. Am J Gastroenterol 101(10):2223–2229
45. Dresner SM, Griffin SM (2000) Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 87(10):1426–1433
46. Pech O, May A, Manner H, et al (2011) Endoscopic resection in 953 patients with mucosal Barrett’s cancer. Gastrointest Endosc 73(4); Supplement, Page AB1 46 (abstract)
47. Rice TW, Zuccaro G, Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR (1998) Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 65(3):787–792
48. Liu L, Hofstetter WL, Rashid A, Swisher SG, Correa AM, Ajani JA et al (2005) Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 29(8):1079–1085
49. Tian J, Ganapathy AP, Lutzke LS et al (2011) Outcomes of T1b esophageal carcinoma patients. Gastrointest Endosc 74:1201–1206